IRONWOOD PHARMACEUTICALS INC (IRWD) Stock Earnings & Estimates
NASDAQ:IRWD - US46333X1081 - Common Stock
1.32 USD
0 (0%)
1.31 USD
-0.01 (-0.76%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 410.596M -0.76% | 442.735M 7.83% | 351.41M -20.63% | 279.82M -20.37% | 256.63M -8.29% | 182.58M -28.85% | 183.09M 0.28% | 155.55M -15.04% | 152.49M -1.97% | 161.16M 5.69% | 179.01M 11.08% | |
| EBITDA YoY % growth | 251.755M 7.76% | 169.911M -32.51% | 97.728M -42.48% | 104.04M 6.46% | 98.022M -5.78% | 16.32M -83.35% | 7.14M -56.25% | -5.1M -171.43% | -1.02M 80.00% | 33.66M 3,400.00% | 72.42M 115.15% | |
| EBIT YoY % growth | 250.337M 7.85% | 168.336M -32.76% | 95.717M -43.14% | 81.498M -14.86% | 75.072M -7.88% | -8.16M -110.87% | -11.22M -37.50% | -31.11M -177.27% | -28.05M 9.84% | -9.69M 65.45% | 12.75M 231.58% | |
| Operating Margin | 60.97% | 38.02% | 27.24% | 29.13% | 29.25% | -4.47% | -6.13% | -20.00% | -18.39% | -6.01% | 7.12% | |
| EPS YoY % growth | 0.97 -17.80% | 0.64 -34.02% | 0.02 -96.88% | 0.21 971.00% | 0.00 -100.00% | -0.09 | -0.07 22.22% | -0.16 -128.57% | -0.12 28.13% | -0.01 95.65% | 0.13 2,600.00% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.09 359.00% | 0.11 461.00% | 0.02 114.57% | 0.00 -100.00% | 0.03 -66.67% | 0.00 -100.00% |
| Revenue Q2Q % growth | 74.358M -18.82% | 76.84M -15.14% | 53.091M 29.04% | 58.956M -30.83% | N/A | 68.289M -11.13% |
| EBITDA Q2Q % growth | 30.906M 13.72% | 39.525M 17.72% | 10.047M 198.80% | N/A | N/A | N/A |
| EBIT Q2Q % growth | 34.068M 32.81% | 37.74M 19.57% | -4.386M 58.81% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.14 | 0.04 | 0.10 | 243.14% |
| Q1 2025 Q2Q % growth | -0.14 -600.00% | -0.05 | -0.09 | -194.10% |
| Q4 2024 Q2Q % growth | 0.02 300.00% | 0.08 | -0.06 | -74.94% |
| Q3 2024 Q2Q % growth | 0.02 -77.78% | 0.08 | -0.06 | -75.67% |
| Q2 2024 Q2Q % growth | 0.00 -100.00% | 0.16 | -0.16 | -100.00% |
| Q1 2024 Q2Q % growth | -0.02 -108.00% | 0.19 | -0.21 | -110.27% |
| Q4 2023 Q2Q % growth | -0.01 -103.70% | 0.21 | -0.22 | -104.77% |
| Q3 2023 Q2Q % growth | 0.09 -67.86% | 0.16 | -0.07 | -43.98% |
| Q2 2023 Q2Q % growth | 0.31 47.62% | 0.25 | 0.06 | 23.21% |
| Q1 2023 Q2Q % growth | 0.25 19.05% | 0.25 | 0.00 | 1.07% |
| Q4 2022 Q2Q % growth | 0.27 | 0.28 | -0.01 | -1.96% |
| Q3 2022 Q2Q % growth | 0.28 -15.15% | 0.27 | 0.01 | 3.59% |
| Q2 2022 Q2Q % growth | 0.21 -38.24% | 0.30 | -0.09 | -30.21% |
| Q1 2022 Q2Q % growth | 0.21 -12.50% | 0.26 | -0.05 | -19.26% |
| Q4 2021 Q2Q % growth | 0.27 -25.00% | 0.36 | -0.09 | -25.08% |
| Q3 2021 Q2Q % growth | 0.33 43.48% | 0.32 | 0.01 | 4.36% |
| Q2 2021 Q2Q % growth | 0.34 112.50% | 0.23 | 0.11 | 44.93% |
| Q1 2021 Q2Q % growth | 0.24 500.00% | 0.21 | 0.03 | 14.22% |
| Q4 2020 Q2Q % growth | 0.36 20.00% | 0.29 | 0.07 | 22.38% |
| Q3 2020 Q2Q % growth | 0.23 -42.50% | 0.16 | 0.07 | 48.35% |
| Q2 2020 Q2Q % growth | 0.16 60.00% | 0.09 | 0.07 | 78.25% |
| Q1 2020 Q2Q % growth | 0.04 115.38% | 0.05 | -0.01 | -21.57% |
| Q4 2019 Q2Q % growth | 0.30 | 0.24 | 0.06 | 24.40% |
| Q3 2019 Q2Q % growth | 0.40 | 0.11 | 0.29 | 251.93% |
| Q2 2019 Q2Q % growth | 0.10 | -0.03 | 0.13 | 441.48% |
| Q1 2019 Q2Q % growth | -0.26 | -0.14 | -0.12 | -88.02% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 85.239M -9.70% | 61.991M | 23.248M | 37.50% |
| Q1 2025 Q2Q % growth | 41.143M -45.05% | 46.9M | -5.757M | -12.28% |
| Q4 2024 Q2Q % growth | 90.545M -22.98% | 95.698M | -5.153M | -5.38% |
| Q3 2024 Q2Q % growth | 91.592M -19.47% | 93.073M | -1.481M | -1.59% |
| Q2 2024 Q2Q % growth | 94.396M -12.09% | 109.14M | -14.744M | -13.51% |
| Q1 2024 Q2Q % growth | 74.877M -28.05% | 107.92M | -33.043M | -30.62% |
| Q4 2023 Q2Q % growth | 117.553M 9.66% | 119.83M | -2.277M | -1.90% |
| Q3 2023 Q2Q % growth | 113.739M 4.70% | 115.15M | -1.411M | -1.23% |
| Q2 2023 Q2Q % growth | 107.382M 10.44% | 105.79M | 1.592M | 1.50% |
| Q1 2023 Q2Q % growth | 104.061M 6.70% | 102.42M | 1.641M | 1.60% |
| Q4 2022 Q2Q % growth | 107.199M -8.48% | 113.06M | -5.861M | -5.18% |
| Q3 2022 Q2Q % growth | 108.637M 4.71% | 111.54M | -2.903M | -2.60% |
| Q2 2022 Q2Q % growth | 97.231M -6.54% | 105.58M | -8.349M | -7.91% |
| Q1 2022 Q2Q % growth | 97.529M 9.83% | 96.242M | 1.287M | 1.34% |
| Q4 2021 Q2Q % growth | 117.13M 0.37% | 112.07M | 5.06M | 4.52% |
| Q3 2021 Q2Q % growth | 103.747M 0.24% | 107.51M | -3.763M | -3.50% |
| Q2 2021 Q2Q % growth | 104.031M 16.37% | 94.316M | 9.715M | 10.30% |
| Q1 2021 Q2Q % growth | 88.8M 11.14% | 97.104M | -8.304M | -8.55% |
| Q4 2020 Q2Q % growth | 116.7M -7.60% | 114.19M | 2.51M | 2.20% |
| Q3 2020 Q2Q % growth | 103.5M -21.11% | 97.882M | 5.618M | 5.74% |
| Q2 2020 Q2Q % growth | 89.4M -12.52% | 87.968M | 1.432M | 1.63% |
| Q1 2020 Q2Q % growth | 79.9M 16.30% | 80.23M | -330K | -0.41% |
| Q4 2019 Q2Q % growth | 126.3M | 114.09M | 12.21M | 10.70% |
| Q3 2019 Q2Q % growth | 131.2M | 99.041M | 32.159M | 32.47% |
| Q2 2019 Q2Q % growth | 102.2M | 91.414M | 10.786M | 11.80% |
| Q1 2019 Q2Q % growth | 68.7M | 83.936M | -15.236M | -18.15% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -30.77% | 4.96% | 13.51% | 10.53% |
| Revenue | -8.9% | -2.41% | 1.38% | 1.38% |